EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 ATTENUATES THE GLYCAEMIC RESPONSE TO ENTERAL NUTRIENT IN CRITICALLY ILL PATIENTS WITH PRE-EXISTING TYPE-2 DIABETES MELLITUS

被引：0
|
作者：
Deane, A. [1 ,2 ]
Chapman, M. J. [1 ,2 ]
Fraser, R. J. [3 ]
Summers, M. J. [4 ]
Zaknic, A. V. [4 ]
DiBartolomeo, A. [2 ]
Horowitz, M. [3 ]
机构：
[1] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia
来源：
INTENSIVE CARE MEDICINE | 2010年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0346
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [1] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Deane, Adam M.
    Summers, Matthew J.
    Zaknic, Antony V.
    Chapman, Marianne J.
    Fraser, Robert J. L.
    Di Bartolomeo, Anna E.
    Wishart, Judith M.
    Horowitz, Michael
    CRITICAL CARE, 2011, 15 (01):
  • [2] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Adam M Deane
    Matthew J Summers
    Antony V Zaknic
    Marianne J Chapman
    Robert JL Fraser
    Anna E Di Bartolomeo
    Judith M Wishart
    Michael Horowitz
    Critical Care, 15
  • [3] DRY POWDER INHALATION OF GLUCAGON-LIKE PEPTIDE-1 FOR MANAGEMENT OF TYPE-2 DIABETES MELLITUS
    Pandya, Sanketkumar
    Kumar, Durgesh
    Gupta, Swati
    Mitra, Kalyan
    Gaikwad, Anil N.
    Misra, Amit
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : A19 - A19
  • [4] Exogenous Glucagon-Like Peptide-1 for Hyperglycemia in Critically III Patients
    Pinelli, Nicole R.
    Jones, Mathew C.
    Monday, Lea M.
    Smith, Zachary
    Rhoney, Denise H.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 124 - 129
  • [5] Improving Glucagon-like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus
    Freeman, Jeffrey S.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S2 - S6
  • [6] Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?
    Juris J Meier
    Michael A Nauck
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 606 - 607
  • [7] Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?
    Meier, Juris J.
    Nauck, Michael A.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (11): : 606 - 607
  • [8] Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus
    Cuthbertson, Joy
    Patterson, Steven
    O'Harte, Finbarr P.
    Bell, Patrick M.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01): : 52 - 56
  • [9] Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
    Holst, JJ
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (06) : 430 - 441
  • [10] Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
    Harris, Kira B.
    McCarty, Delilah J.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 3 - 18
12345